Brain Tumor Diagnosis Using PET with Angiogenic Vessel-Targeting Liposomes
- 10 May 2011
- book chapter
- Published by Springer Nature
- p. 169-176
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- A novel DDS strategy, “dual-targeting”, and its application for antineovascular therapyCancer Letters, 2010
- Angiogenic Vessel-Targeting DDS by Liposomalized Oligopeptides2009
- III. Angiogenesis: Complexity of Tumor Vasculature and MicroenvironmentCurrent Pharmaceutical Design, 2009
- Particle size-dependent triggering of accelerated blood clearance phenomenonInternational Journal of Pharmaceutics, 2008
- Clinical Applications of PET in Brain TumorsJournal of Nuclear Medicine, 2007
- Long-circulating liposomes radiolabeled with [18F]fluorodipalmitin ([18F]FDP)Nuclear Medicine and Biology, 2007
- Enhancement of Anticancer Activity in Antineovascular Therapy Is Based on the Intratumoral Distribution of the Active Targeting Carrier for Anticancer DrugsBiological and Pharmaceutical Bulletin, 2006
- Synthesis of angiogenesis-targeted peptide and hydrophobized polyethylene glycol conjugateBioorganic & Medicinal Chemistry Letters, 2004
- Anti‐neovascular therapy by liposomal drug targeted to membrane type‐1 matrix metalloproteinaseInternational Journal of Cancer, 2003
- Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: Therapeutic implicationsSeminars in Oncology, 2002